What Jounce Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Drapkin Kimberlee C | President, CFO and Treasurer | May 03 | Tender Offer · U | −40,267 | — | — | 0 |
| Drapkin Kimberlee C | President, CFO and Treasurer | May 03 | Tender Offer · U | −25,751 | — | — | 40,267 |
| Tang Kevin | Director | May 03 | Other Transaction · J | +10,000 | $9,737.70 | +$97.4M | 10,000 |
| Tang Kevin | Director | May 03 | Tender Offer · U | −5,300,087 | $1.85 | −$9.81M | 0 |
| Kamen Robert | Director | May 03 | Tender Offer · U | −33,875 | — | — | 0 |
| Kamen Robert | Director | May 03 | Tender Offer · U | −60,975 | — | — | 0 |
| Karsen Perry A | Director | May 03 | Tender Offer · U | −5,000 | — | — | 0 |
| Murray Richard /CA/ | Director | May 03 | Tender Offer · U | −188,778 | — | — | 1 |
| Concentra Biosciences, Llc | 10% owner | May 03 | Other Transaction · J | +10,000 | $9,737.70 | +$97.4M | 10,000 |
| Murray Richard /CA/ | Director | Apr 04 | Open-market sale · S | −39,228 | $1.85 | −$72.6K | 188,779 |
| Tang Kevin | 10% owner | Mar 14 | Open-market buy · P | +20,286 | $1.02 | +$20.7K | 5,300,087 |
| Tang Kevin | 10% owner | Mar 13 | Open-market buy · P | +65,701 | $0.99 | +$65.3K | 5,279,801 |
| Drapkin Kimberlee C | CFO and Treasurer | Jan 10 | Open-market sale · S | −7,781 | $1.12 | −$8.71K | 66,018 |
| Cole Hugh M | Chief Operating Officer | Jan 10 | Open-market sale · S | −9,182 | $1.12 | −$10.3K | 110,082 |
| Murray Richard /CA/ | CEO and President | Jan 10 | Open-market sale · S | −24,879 | $1.12 | −$27.9K | 228,007 |
| Trehu Elizabeth | Chief Medical Officer | Jan 10 | Open-market sale · S | −5,126 | $1.12 | −$5.74K | 103,417 |
| Drapkin Kimberlee C | CFO and Treasurer | Jan 09 | Open-market sale · S | −6,315 | $1.10 | −$6.95K | 73,799 |
| Cole Hugh M | Chief Operating Officer | Jan 09 | Open-market sale · S | −7,452 | $1.10 | −$8.2K | 119,264 |
| Murray Richard /CA/ | CEO and President | Jan 09 | Open-market sale · S | −20,191 | $1.10 | −$22.2K | 252,886 |
| Trehu Elizabeth | Chief Medical Officer | Jan 09 | Open-market sale · S | −4,159 | $1.10 | −$4.57K | 108,543 |
Loading...
